FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing byintegrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options.
| Website | http://www.fluidformbio.com |
| Employees | 14 (7 on RocketReach) |
| Founded | 2018 |
| Address | 283 Bear Hill Rd, Waltham, Massachusetts 02451, US |
| Industry | Biotechnology Research |
| Keywords | Tissue Engineering, Bioprinting, Regenerative Medicine, Tissue Regeneration, 3d Bioprinting, Human Tissue, Cellular Agriculture, Disease Treatment, Biofabrication, Organoids, Biotechnology, Cell Culture, Pharmaceutical, Protein Engineering, Therapeutic Proteins, Biomaterials, Drug Discovery, Medical Technology |
| Competitors | Integra LifeSciences, Acelity, Organogenesis, Sientra, Inc., MediWound Ltd., Cerapedics Inc., Tissue Regenix Group, Axovant Sciences Ltd +34 more (view full list) |
Looking for a particular FluidForm Bio employee's phone or email?
Andrew Hudson is the Senior Director of Tissue Therapeutics and Co-Founder of FluidForm Bio.
7 people are employed at FluidForm Bio.
FluidForm Bio is based in Waltham, Massachusetts.